Insud Pharma - About the company
Insud Pharma is a funded company based in Madrid (Spain), founded in 1977 by Hugo Sigman. It operates as a Developer and manufacturer of finished formulations, APIs and monoclonal antibodies. Insud Pharma has raised an undisclosed amount in funding. The company has 364 active competitors, including 22 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Syngene.
Company Details
Insud Pharma develops and manufactures finished dosage forms (FDFs), active pharmaceutical ingredients (APIs), and monoclonal antibodies to fight cancer and autoimmune diseases. The company operates through three business areas, API production(Chemo), branded generics (Exeltis) and biologics (mAbxience). They mainly focus on therapeutic areas including cardiovascular, gastroenterology, central nervous system, anti-infective, respiratory, women's health, endocrinology, dermatology, and urology.
- Website
- www.insudpharma.com/
- Social
- Email ID
- *****@insudpharma.com
- Phone Number
- +34 **********
- Registered Address
- 5/2, Industrial Area, Kirti Nagar, West Delhi, New Delhi, Delhi, India, 110015
Key Metrics
Founded Year
1977
Location
Madrid, Spain
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
16th among 364 active competitors
Employee Count
7,294 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with Insud Pharma
Insud Pharma is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
INDUS PHARMA PRIVATE LIMITED CIN: U74899DL1987PTC026657 , India, Active | Jan 12, 1987 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | 12 (As on Aug 31, 2025) |
Sign up to download Insud Pharma's company profile
Insud Pharma's funding and investors
Insud Pharma has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Nov 22, 2024 for $*****. 1 investor participated in its latest round. Insud Pharma has 1 institutional investor.
Here is the list of recent funding rounds of Insud Pharma:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 22, 2024 | 6807905 | Grant (prize money) | 9213449 | 6584386 | 6778644 | 3765174 |
Access funding benchmarks and valuations. Sign up today!View details of Insud Pharma's funding rounds and investors
Insud Pharma's founders and board of directors
Founder? Claim ProfileThe founders of Insud Pharma is Hugo Sigman.
Here are the details of Insud Pharma's key team members:
- Hugo Sigman: Co-Founder of Insud Pharma.
View details of Insud Pharma's Founder profiles and Board Members
Insud Pharma's employee count trend
Insud Pharma has 7,294 employees as of Sep 26. Here is Insud Pharma's employee count trend over the years:
Uncover Insud Pharma's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Insud Pharma's Competitors and alternates
Top competitors of Insud Pharma include Anthem Biosciences, Patheon and Syngene. Here is the list of Top 10 competitors of Insud Pharma, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Anthem Biosciences 2006, Bengaluru (India), Public | Developer of integrated contract research development and manufacturing services | $35.7M | 75/100 | |
2nd | Patheon 1974, Durham (United States), Acquired | Global CDMO providing integrated drug development, clinical trials, and manufacturing services | $141M | 74/100 | |
3rd | Provider of contract research and manufacturing services for both small molecules and biologics | $85.9M | 72/100 | ||
4th | Abingdon Health 2008, York (United Kingdom), Public | Developer of immunoassays for diagnostic purposes | $24.1M | 64/100 | |
5th | Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired | Aseptic manufacturing CDMO providing fill-finish services for sterile injectables | $16.9M | 59/100 | |
6th |  Abzena 2001, Cambridge (United Kingdom), Acquired | Provider of antibody discovery, cell line development, and bio analytics services | $67.1M | 58/100 | |
7th | Contract development and manufacturing organization for biologics | - | 58/100 | ||
8th |  Daewoong Pharmaceutical 1945, Seoul (South Korea), Public | Developer of therapies for treating gastrointestinal disorders | - | 57/100 | |
9th | Kemwell Biopharma 1980, Bengaluru (India), Acquired | A biologics CDMO providing integrated development and manufacturing | $5.72M | 57/100 | |
10th | KBI Biopharma 1996, Durham (United States), Acquired | Provider of protein formulation, process & cell line development, and cGMP services | $21M | 56/100 | |
16th |  Insud Pharma 1977, Madrid (Spain), Funding Raised | Developer and manufacturer of finished formulations, APIs and monoclonal antibodies | - | 56/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Insud Pharma's competitors? Click here to see the top ones
Insud Pharma's Investments and acquisitions
Insud Pharma has made 5 investments in companies including Procaps Group and Procaps Group. Insud Pharma has also acquired 3 companies including Agile Therapeutics and Viatris.Here is the list of investments & acquisitions:
Filter this list
Filter this listDate of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 09, 2025 | Investments | 1999 | Miami (United States) | |
Aug 26, 2024 | Acquisition | 1997 | Princeton (United States) | |
Mar 16, 2024 | Acquisition | 1998 | Frankfurt (Germany) |
Want to know more about where corporates are investing? Sign up today!See all investments by Insud Pharma
Reports related to Insud Pharma
Here is the latest report on Insud Pharma's sector:
News related to Insud Pharma
Filter this listMedia has covered Insud Pharma for 1 event in last 1 year, It was about people movement.
•
Insud Pharma to invest 100 million in its Alcala (Madrid) center and create 100 jobsPressDigital•Mar 06, 2026•Insud Pharma
•
Insud Pharma Receives $2.7M Gates Foundation Grant to Develop Sublingual Oxytocin for Postpartum HemorrhageFemtech Insider•Nov 22, 2024•Insud Pharma, Gates
•
New alliance for the development of an oxytocin sublingual formulation intended to prevent postpartum hemorrhagesPR Newswire•Nov 21, 2024•Insud Pharma, Gates
•
•
Agile Therapeutics Inc. Announces Completion of Acquisition by Insud Pharma, S.L.ForexTV•Aug 27, 2024•Agile Therapeutics, Insud Pharma
•
Agile Therapeutics to be acquired by Spain-based Insud for an enterprise value of ~$45MSeeking Alpha•Jun 26, 2024•Agile Therapeutics, Insud Pharma, Exeltis
•
Idorsia and Viatris successfully close the transaction for the global research and development collaborationGlobeNewswire•Mar 18, 2024•Idorsia, Viatris, Insud Pharma
•
An Argentine company became the largest contraceptive manufacturer in the worldesdelatino.com•Mar 16, 2024•Insud Pharma, Viatris
•
Moolec Science Announces US $30 Million Capital Raise With Strategic InvestorsACN Newswire•Oct 17, 2023•Moolec Science, Insud Pharma, Bioceres Crop Solutions
•
Spain antitrust watchdog fines Merck 39 million euros in contraceptives caseReuters•Oct 25, 2022•Merck, Insud Pharma
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Insud Pharma
Explore our recently published companies
- Hausland Group - Philippines based, 1986 founded, Unfunded company
- Grafeas - San Francisco based, Unfunded company
- YaController - Russia based, Unfunded company
- Lo And Behold - United Kingdom based, Unfunded company
- RTI Design - Latvia based, Unfunded company
- ABI GLOBAL FZ - United States based, 2018 founded, Unfunded company
